Market Research Logo

Mozambique Pharmaceuticals and Healthcare Report Q2 2016

Mozambique Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The Mozambican health sector has suffered from years of neglect and the damage caused by adevastatingly long civil war. In recent years, the government has shown its commitment to improving thecountry's healthcare infrastructure and we expect increasing public expenditure, coupled with a highdisease burden, to continue driving the demand for medicines over the long-term. However, we note thatweak intellectual property protection and a poor regulatory environment continue to plague the market.

These issues are unlikely to be sufficiently addressed in the foreseeable future, especially considering theincreasingly tense political climate.

Headline Expenditure Forecasts

Pharmaceuticals: MZN8.28bn (USD210mn) in 2015 to MZN9.02bn (USD184mn) in 2016; +8.9% inlocal currency and -12.3% in US dollar terms. Forecast in line with last quarter.

Healthcare: MZN38.89bn (USD985mn) in 2015 to MZN43.15bn (USD881mn) in 2016; +10.9% in localcurrency and -10.6% in US dollar terms. Forecast in line with last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Mozambique 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Mozambique 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Mozambique 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Mozambique 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mozambique 2012-2020)
Industry Risk Reward Index
Middle East and Africa Risk/Reward Index - Q2 2016
Mozambique Risk/Reward Index
Rewards
Risks
Regulatory Review
Regulatory Development
Intellectual Property Issues
Pricing Regime
Market Overview
Healthcare Sector
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Sociedade Moçambicana de Medicamentos (SMM)
Demographic Forecast
Table: Population Headline Indicators (Mozambique 1990-2025)
Table: Key Population Ratios (Mozambique 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Mozambique 1990-2025)
Table: Population By Age Group (Mozambique 1990-2025)
Table: Population By Age Group % (Mozambique 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report